BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260306
DTSTAMP:20260508T020907
CREATED:20251126T003017Z
LAST-MODIFIED:20251126T003058Z
UID:10000405-1772582400-1772755199@oncodaily.com
SUMMARY:ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists\, focusing on using precision medicine to manage patients with HR-positive\, HER2-negative metastatic breast cancer. \nThe event is scheduled to take place on March 4–5\, 2026\, in Zurich\, Switzerland. \nThe application deadline for participation is January 7\, 2026\, at 23:59 CET. The course objectives include understanding the rationale and technical background of biomarker testing\, using results for optimal patient selection\, and discussing the proactive management of precision-medicine-based treatments. \nApply.
URL:https://oncodaily.com/event/breast-cancer-416477
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-2-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260308
DTSTAMP:20260508T020907
CREATED:20251221T215815Z
LAST-MODIFIED:20251221T215832Z
UID:10000517-1772755200-1772927999@oncodaily.com
SUMMARY:ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. \nScheduled for March 6–7\, 2026\, in Zurich\, Switzerland\, the course focuses on multidisciplinary care\, evidence-based management\, and the interpretation of novel translational research\, including molecular profiling and clinical trials. \nLed by co-chairs Viktor Gruenwald and Bernadett Szabados\, the program offers successful applicants complimentary registration\, accommodation\, and a travel grant\, emphasizing ESMO’s commitment to advancing professional expertise in bladder cancer treatment. \nApplication.
URL:https://oncodaily.com/event/esmo-432406
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260311
DTEND;VALUE=DATE:20260314
DTSTAMP:20260508T020907
CREATED:20251126T122443Z
LAST-MODIFIED:20251126T122508Z
UID:10000407-1773187200-1773446399@oncodaily.com
SUMMARY:ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester
DESCRIPTION:The ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13\, 2026\, in Manchester\, United Kingdom. \nThe application deadline is January 21\, 2026\, at 23:59 CET\, and the course is accredited for 16 ESMO-MORA category 1 points. \nThe learning objectives cover the full spectrum of thoracic oncology\, from screening and management of early-stage non-small cell lung cancer (NSCLC) to multi-modality treatment for locally advanced disease and systemic therapy for mesothelioma and small-cell lung cancer (SCLC)\, with a focus on advanced treatments like targeted agents for actionable driver mutations\, novel immunotherapies\, and palliative care. \nApply.
URL:https://oncodaily.com/event/esmo-the-christie-preceptorship416745
LOCATION:Manchester\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-Christie.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20260312T080000
DTEND;TZID=Europe/Zurich:20260314T170000
DTSTAMP:20260508T020907
CREATED:20250710T195346Z
LAST-MODIFIED:20250710T195614Z
UID:10000209-1773302400-1773507600@oncodaily.com
SUMMARY:The ESMO Sarcoma and Rare Cancers Congress 2026
DESCRIPTION:The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano\, Switzerland\, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. \nThe congress will discuss the latest developments in diagnosis\, treatment\, molecular biology\, and classification of sarcomas and other rare cancers. The programme includes a wide range of sessions such as abstract presentations\, educational lectures\, multidisciplinary tumour boards\, guidelines updates\, and dedicated discussions for young oncologists. With opportunities for clinicians\, researchers\, industry professionals\, and patient advocates to connect and collaborate\, the congress promises three days of enriching scientific exchange and community building in the field of rare cancers.
URL:https://oncodaily.com/event/esmo-326996
LOCATION:“Palazzo dei Congressi” in Lugano\, Switzerland\, Piazza Indipendenza 4\, Lugano\, 6900\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7057.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260316
DTEND;VALUE=DATE:20260319
DTSTAMP:20260508T020907
CREATED:20251114T213627Z
LAST-MODIFIED:20251114T213641Z
UID:10000355-1773619200-1773878399@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies Congress 2026
DESCRIPTION:The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO)\, focused on accelerating the delivery of life-changing anticancer therapies through early drug development. \nThe congress will be held from March 16 to 18\, 2026\, at the Palais des Congrès in Paris\, France. The event serves as a dynamic\, multi-stakeholder meeting\, uniting researchers\, industry leaders\, investors\, and regulators to share new data\, foster collaboration\, and tackle the challenges of advancing early clinical development in oncology. \nElena Garralda\, Carlos Gomez-Roca\, and Cristian Massacesi serve as the co-chairs.
URL:https://oncodaily.com/event/esmo-409793
LOCATION:Palais des Congrès de Paris\, 2 Pl de la Pte Maillot\, Paris\, Île-de-France\, 75017\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7078.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260319T080000
DTEND;TZID=Europe/Madrid:20260321T170000
DTSTAMP:20260508T020907
CREATED:20250719T103826Z
LAST-MODIFIED:20250801T203138Z
UID:10000223-1773907200-1774112400@oncodaily.com
SUMMARY:The ICHNO 2026
DESCRIPTION:The ICHNO 2026\, the 10th International Congress on Innovative Approaches in Head and Neck Oncology\, will be held from 19–21 March 2026 in Seville\, Spain\, under the theme: “Driven by Biology\, Centred on the Person.”  \nThis unique event—jointly organized by ESTRO\, EHNS\, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the latest advances in head and neck oncology\, grounded in biology and focused on the individual. \nWith global thought leaders\, impactful research\, and opportunities for meaningful dialogue\, ICHNO 2026 will be a vital platform for education\, exchange\, and collaboration. The Chairpersons of the 10th ICHNO Congress are Mererid Evans (ESTRO)\, Giovanni Succo (EHNS)\, and Yungan Tao (ESMO). \nMore posts featuring European Society for Radiotherapy and Oncology on OncoDaily.
URL:https://oncodaily.com/event/the-ichno-2026-332267
LOCATION:Fibes – Conference and Exhibition\, Ave. Alcalde Luis Uruñuela\, 1\, Seville\, 41020\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/IMG_7601.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260326
DTSTAMP:20260508T020907
CREATED:20251228T200222Z
LAST-MODIFIED:20251228T200236Z
UID:10000539-1774396800-1774483199@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Endometrial Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Endometrial Cancer 2026 is a specialized virtual scientific meeting scheduled for March 25\, 2026\, focused on the practical application of clinical practice guidelines in the management of endometrial cancer. \nChaired by Ana Oaknin\, the webinar features a multidisciplinary panel of experts who discuss the diagnosis\, staging\, and therapeutic sequencing for endometrial malignancies through the lens of a real-world clinical case. The session provides oncology professionals with 1 ESMO-MORA category 1 point and serves as a forum for translating the latest ESMO Clinical Practice Guidelines into individualized patient care. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-435260
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Copenhagen:20260325T080000
DTEND;TZID=Europe/Copenhagen:20260328T170000
DTSTAMP:20260508T020907
CREATED:20250712T062245Z
LAST-MODIFIED:20250712T062307Z
UID:10000211-1774425600-1774717200@oncodaily.com
SUMMARY:The European Lung Cancer Congress (ELCC 2026)
DESCRIPTION:The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen\, Denmark\, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science\, sharing education\, and enhancing lung cancer care practices globally. \nWith a comprehensive programme designed for medical oncologists\, radiation oncologists\, thoracic surgeons\, respiratory physicians\, interventional radiologists\, and pathologists\, ELCC 2026 offers valuable learning and networking opportunities. Participants are invited to engage in interactive sessions and connect with lung cancer specialists from around the world.
URL:https://oncodaily.com/event/elcc-2026-327158
LOCATION:Bella Center\, Center Boulevard 5\, Copenhagen\, 2300\, Denmark
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7077.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260329
DTSTAMP:20260508T020907
CREATED:20251228T200812Z
LAST-MODIFIED:20251228T200821Z
UID:10000540-1774569600-1774742399@oncodaily.com
SUMMARY:ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing
DESCRIPTION:The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled for March 27–28\, 2026\, in Beijing\, China. \nCo-chaired by Giuseppe Curigliano and Binghe Xu\, this 1.5-day course is specifically designed for experienced oncologists and oncology specialists to deepen their understanding of CDK4/6 inhibition in both early and metastatic HR+/HER2- breast cancer settings. The course is accredited with 11 ESMO-MORA category 1 points\, serving as a vital platform for clinicians in the Asia-Pacific region to integrate the latest evidence into precision breast cancer management. \nApplication.
URL:https://oncodaily.com/event/esmo-advanced-course-435266
LOCATION:Beijing\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-3.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260401
DTEND;VALUE=DATE:20260402
DTSTAMP:20260508T020907
CREATED:20251228T201317Z
LAST-MODIFIED:20251228T201327Z
UID:10000541-1775001600-1775087999@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026 webinar\, scheduled for April 1\, 2026\, focuses on the integration of precision diagnostics and innovative therapies in the management of Renal Cell Carcinoma (RCC). \nChaired by Viktor Gruenwald\, the program addresses the clinical challenges of treatment sequencing and patient selection in a rapidly evolving therapeutic landscape. Key sessions cover molecular tailoring for treatment stratification\, the emergence of molecular imaging as a diagnostic and therapeutic tool\, and evidence-based strategies for second-line management of metastatic RCC. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-435270
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260415
DTEND;VALUE=DATE:20260416
DTSTAMP:20260508T020907
CREATED:20260128T213438Z
LAST-MODIFIED:20260128T213455Z
UID:10000640-1776211200-1776297599@oncodaily.com
SUMMARY:ESMO Therapeutic Landscapes Webinar: Tumour Agnostics 2026
DESCRIPTION:The ESMO Therapeutic Landscapes Webinar: Tumour Agnostics 2026 is a specialized virtual session scheduled for Wednesday\, April 15\, 2026\, from 18:30 to 19:30 CEST. Part of a new educational series designed to keep oncology professionals at the forefront of emerging management strategies\, this webinar focuses on the shift toward treating cancers based on specific molecular alterations rather than their organ of origin. \nThe program aims to explore the latest scientific advances in precision medicine\, highlighting breakthroughs in tumor-agnostic drug development – such as NTRK fusions and microsatellite instability (MSI) – and discussing the practical challenges of integrating these therapies into clinical practice. Participants can earn 1 ESMO-MORA category 1 point for live attendance\, which provides a deeper understanding of the evolving landscape of molecular oncology. \nRegister.
URL:https://oncodaily.com/event/esmo-therapeutic-landscapes-448596
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260415
DTEND;VALUE=DATE:20260417
DTSTAMP:20260508T020907
CREATED:20251126T123548Z
LAST-MODIFIED:20251126T123607Z
UID:10000408-1776211200-1776383999@oncodaily.com
SUMMARY:ESMO Preceptorship on Gastroesophageal Cancer 2026: Bogota
DESCRIPTION:The ESMO Preceptorship on Gastroesophageal Cancer 2026: Bogota is a two-day educational course aimed primarily at oncologists resident in Latin America. It will be held from April 15–16\, 2026\, in Bogota\, Colombia. \nThe application deadline for this preceptorship is February 1\, 2026\, at 23:59 CET. Successful applicants receive complimentary course registration and accommodation\, and a travel grant of up to 800 euros is offered to selected participants. \nApply.
URL:https://oncodaily.com/event/preceptorship-on-gastroesophageal-cancer-416774
LOCATION:Bogota\, Colombia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-2-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260415
DTEND;VALUE=DATE:20260417
DTSTAMP:20260508T020907
CREATED:20251228T201833Z
LAST-MODIFIED:20251228T201844Z
UID:10000542-1776211200-1776383999@oncodaily.com
SUMMARY:ESMO Preceptorship on Breast Cancer 2026: Bogota
DESCRIPTION:The ESMO Preceptorship on Breast Cancer 2026: Bogota is an educational course scheduled for April 15–16\, 2026\, in Bogotá\, Colombia. \nCo-chaired by Carlos Barrios and Nadia Harbeck\, this intensive meeting is primarily aimed at oncologists in Latin America to foster interdisciplinary collaboration and improve subtype-specific breast cancer management. The technical program covers the latest advancements in radiological diagnostics\, neoadjuvant and adjuvant therapies\, and specialized care for young patients and those with advanced disease. \nApplication.
URL:https://oncodaily.com/event/esmo-preceptorship-on-breast-cancer-435278
LOCATION:Bogota\, Colombia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Preceptorship-on-Breast-Cancer-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260417
DTEND;VALUE=DATE:20260419
DTSTAMP:20260508T020907
CREATED:20251228T202535Z
LAST-MODIFIED:20251228T202551Z
UID:10000543-1776384000-1776556799@oncodaily.com
SUMMARY:ESMO Summit Latin America 2026
DESCRIPTION:The ESMO Summit Latin America 2026 is a premier educational meeting scheduled for April 17-18\, 2026\, in Bogotá\, Colombia. \nOrganized by the European Society for Medical Oncology (ESMO) in collaboration with the Colombian Association of Hematology and Oncology (ACHO)\, this two-day summit provides a comprehensive technical review of practice-changing clinical studies and international standards of care. \nThe program is specifically tailored to the regional needs of the Latin American oncology community\, featuring expert-led presentations on key tumor types\, interactive workshops\, and clinical case discussions. Co-chaired by Paula Anel Cabrera-Galeana\, Nadia Harbeck\, and Ray Manneh Kopp\, the event aims to facilitate the integration of the latest oncological breakthroughs into local practice and is typically accredited with ESMO-MORA category-1 CME points. \nRegister.
URL:https://oncodaily.com/event/esmo-summit-latin-america-435283
LOCATION:Hilton Bogota Corferias\, Carrera 37 No. 24 29\, Bogotá\, Bogotá D.C.\, 111321\, Colombia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Latin-America.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260425
DTSTAMP:20260508T020907
CREATED:20260120T145446Z
LAST-MODIFIED:20260120T145452Z
UID:10000603-1776902400-1777075199@oncodaily.com
SUMMARY:ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026: Athens
DESCRIPTION:The ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026 is an intensive educational meeting scheduled to take place from April 23–24\, 2026\, in Athens\, Greece. \nUnder the leadership of Co-Chairs Helena Linardou\, Giannis Mountzios\, and Solange Peters\, this course is designed to provide oncology professionals with a comprehensive update on the rapidly evolving diagnostic and therapeutic standards for early-stage NSCLC. \nThe program typically emphasizes multidisciplinary management\, covering advancements in neoadjuvant and adjuvant systemic therapies\, surgical innovations\, and the integration of molecular profiling to personalize patient care. Through a combination of expert lectures and interactive discussions\, the event aims to bridge the gap between clinical trial data and real-world practice to improve outcomes for patients with resectable lung cancer. \nApplication.
URL:https://oncodaily.com/event/esmo-advanced-course-444075
LOCATION:Athens\, Greece
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-NSCLC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260429
DTEND;VALUE=DATE:20260430
DTSTAMP:20260508T020907
CREATED:20260104T000501Z
LAST-MODIFIED:20260104T000515Z
UID:10000545-1777420800-1777507199@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Bladder Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Bladder Cancer 2026 is a specialized virtual scientific meeting scheduled for April 29\, 2026\, focused on translating the latest ESMO Clinical Practice Guidelines into clinical practice. \nChaired by Andrea Necchi\, the webinar addresses the rapidly evolving landscape of bladder cancer management\, including the integration of immune checkpoint inhibitors\, antibody–drug conjugates (ADCs)\, and FGFR-targeted therapies. \nThrough a real-world clinical case analysis presented by experts such as Thomas Powles and Ashish Kamat\, the session provides a technical forum for oncology professionals to discuss treatment sequencing\, patient selection\, and the practical implementation of evidence-based standards. Attendees are eligible for 1 ESMO-MORA category 1 point for participating in this interactive educational event. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-436359
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260506
DTEND;VALUE=DATE:20260507
DTSTAMP:20260508T020907
CREATED:20260104T000937Z
LAST-MODIFIED:20260104T000945Z
UID:10000546-1778025600-1778111999@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026 is a virtual scientific webinar scheduled for May 6\, 2026. \nThis session focuses on the clinical management of high-risk localized prostate cancer\, a disease state associated with significant risks of recurrence and mortality. Chaired by Deborah Mukherji\, the program features technical discussions led by experts including Stephen Freedland\, Christopher Sweeney\, and Derya Tilki. \nKey topics include advanced risk stratification\, the role of systemic therapies in combination with radiotherapy\, and evidence-based strategies for managing biochemical recurrence. The webinar aims to provide oncology professionals with updated knowledge to individualize treatment approaches and improve long-term outcomes\, awarding 2 ESMO-MORA category 1 points to live participants. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-436363
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Deep-Dive.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260506T080000
DTEND;TZID=Europe/Berlin:20260508T170000
DTSTAMP:20260508T020907
CREATED:20250712T062036Z
LAST-MODIFIED:20250712T062110Z
UID:10000212-1778054400-1778259600@oncodaily.com
SUMMARY:The ESMO Breast Cancer 2026
DESCRIPTION:Join the global breast cancer community at ESMO Breast Cancer 2026\, taking place from 6 to 8 May 2026 in Berlin\, Germany\, or online. \nThis international congress will gather top experts\, researchers\, and clinicians to explore the latest advances in breast cancer care\, covering everything from early detection to innovative treatments and survivorship strategies. \nThe event offers a platform to engage with global leaders\, share real-world insights\, and help shape the future of breast cancer treatment. The Scientific Committee is co-chaired by Masakazu Toi\, Sara Tolaney and Nicholas Turner.
URL:https://oncodaily.com/event/esmo-327164
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7076.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260513
DTSTAMP:20260508T020907
CREATED:20260104T001332Z
LAST-MODIFIED:20260104T001344Z
UID:10000547-1778457600-1778630399@oncodaily.com
SUMMARY:ESMO Preceptorship on Hereditary Cancer Genetics 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Hereditary Cancer Genetics 2026 is an intensive educational course scheduled for May 11–12\, 2026\, in Lugano\, Switzerland. \nCo-chaired by Judith Balmaña and Marjolijn Ligtenberg\, this program is designed to provide oncologists with a comprehensive understanding of the molecular basis of genetic susceptibility to cancer. The technical curriculum focuses on the multidisciplinary management of hereditary cancer syndromes\, the identification and diagnosis of germline genetic mutations\, and the implementation of evidence-based prevention strategies. \nThrough a combination of state-of-the-art lectures and interactive clinical case discussions\, the course aims to equip participants with the skills necessary to provide personalized care for patients with hereditary cancer risks. Successful applicants benefit from complimentary registration and accommodation\, and the event is accredited with 9 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/hereditary-cancer-genetics-436366
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260513
DTEND;VALUE=DATE:20260515
DTSTAMP:20260508T020907
CREATED:20260104T001901Z
LAST-MODIFIED:20260104T001917Z
UID:10000548-1778630400-1778803199@oncodaily.com
SUMMARY:ESMO Preceptorship on Head and Neck Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Head and Neck Cancer 2026 is a specialized educational course scheduled for May 13–14\, 2026\, in Lugano\, Switzerland. \nThis program is designed to provide medical and clinical oncologists with a deep understanding of the management of head and neck cancers\, ranging from diagnosis to advanced treatment strategies. The curriculum covers the epidemiology\, etiology\, and molecular biology of nasopharyngeal cancer (NPC) and head and neck squamous cell carcinoma (HNSCC). \nParticipants will explore multidisciplinary management approaches\, including the roles of surgery\, radiation therapy\, and systemic therapy\, with a particular emphasis on the integration of immunotherapy and the management of rare tumors. The course combines plenary lectures with interactive\, case-based sessions to facilitate direct engagement between participants and international experts. Successful applicants receive complimentary registration and accommodation\, and the event is accredited with 11 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/head-and-neck-cancer-436369
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship-on-Head-and-Neck-Cancer.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260515
DTEND;VALUE=DATE:20260517
DTSTAMP:20260508T020907
CREATED:20260104T234351Z
LAST-MODIFIED:20260104T234406Z
UID:10000549-1778803200-1778975999@oncodaily.com
SUMMARY:ESMO Preceptorship on Colorectal Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Colorectal Cancer 2026: Lugano is a specialized educational course scheduled for May 15–16\, 2026\, in Lugano\, Switzerland. \nThis course is designed to provide oncologists – particularly young and general oncologists – with a comprehensive understanding of colorectal cancer management from diagnosis to treatment. The technical program includes plenary lectures by international experts and interactive case-based sessions\, covering best practices in multidisciplinary management for both adjuvant and metastatic settings\, the role of molecular pathology in prognosis\, and the optimal sequencing of systemic therapies. \nSuccessful applicants benefit from complimentary registration and accommodation\, and the event is accredited with 9 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/colorectal-cancer-2026-436774
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260520
DTEND;VALUE=DATE:20260521
DTSTAMP:20260508T020907
CREATED:20260104T234810Z
LAST-MODIFIED:20260104T234817Z
UID:10000550-1779235200-1779321599@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases Webinar: Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases Webinar: Metastatic Breast Cancer 2026 is a virtual scientific webinar\, scheduled for May 20\, 2026\, that focuses on the practical application of ESMO Clinical Practice Guidelines (CPG) in the management of metastatic breast cancer (MBC). \nChaired by Evandro de Azambuja\, the program features a real-world case presentation by Ana Tecic Vuger\, followed by a critical analysis of the current guidelines by Seock-Ah Im. A multidisciplinary panel\, including experts Nadia Harbeck and Giuseppe Curigliano\, will discuss therapeutic sequencing\, decision-making in advanced disease\, and strategies for overcoming implementation challenges in daily clinical practice. The session provides oncology professionals with 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-436778
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260610
DTEND;VALUE=DATE:20260612
DTSTAMP:20260508T020907
CREATED:20260120T150034Z
LAST-MODIFIED:20260120T150042Z
UID:10000604-1781049600-1781222399@oncodaily.com
SUMMARY:ESMO Preceptorship on Neuroendocrine Neoplasms (NENs) 2026: Hong Kong SAR
DESCRIPTION:The ESMO Preceptorship on Neuroendocrine Neoplasms (NENs) 2026 is a specialized educational meeting scheduled to take place from June 10–11\, 2026\, in Hong Kong SAR\, China. Co-chaired by Nicola Fazio and David Tai\, this course is designed to provide oncology professionals with a thorough grounding in the multidisciplinary management of neuroendocrine tumors\, ranging from diagnosis to advanced therapeutic strategies. \nThe program typically emphasizes the integration of clinical guidelines into practical patient care\, covering the latest developments in pathology\, imaging\, and systemic treatments\, including peptide receptor radionuclide therapy (PRRT). Through expert-led lectures and clinical case discussions\, the preceptorship aims to enhance the clinical expertise of participants and foster international collaboration in the field of rare tumor management. \nApplication.
URL:https://oncodaily.com/event/neuroendocrine-neoplasms-444081
LOCATION:Hong Kong SAR\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-NET-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260612
DTEND;VALUE=DATE:20260615
DTSTAMP:20260508T020907
CREATED:20251126T125513Z
LAST-MODIFIED:20251126T125537Z
UID:10000409-1781222400-1781481599@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies Asia Congress 2026
DESCRIPTION:The ESMO Targeted Anticancer Therapies Asia Congress 2026 will be a three-day event dedicated to advancing cancer drug discovery and precision oncology in the Asia-Pacific region. \n\nDates: June 12–14\, 2026\nLocation: Kerry Hotel\, Hong Kong SAR\, China\nAbstract Submission Deadline: March 31\, 2026\n\nThis congress serves as a key platform for researchers\, industry leaders\, and clinicians to share the latest advances in early-phase drug development and targeted therapies. \nAbstract Submission.
URL:https://oncodaily.com/event/targeted-anticancer-therapies-416778
LOCATION:Kerry Hotel\, Hong Kong\, 38 Hung Luen Road\, Hung Hom Bay\, Kowloon\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-TAT-Asia-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260613
DTEND;VALUE=DATE:20260619
DTSTAMP:20260508T020907
CREATED:20251203T225231Z
LAST-MODIFIED:20251203T225243Z
UID:10000439-1781308800-1781827199@oncodaily.com
SUMMARY:26th Workshop on Methods in Clinical Cancer Research
DESCRIPTION:The 26th Workshop on Methods in Clinical Cancer Research (MCCR workshop) is a prestigious professional development event for oncology researchers\, taking place from June 13–18\, 2026\, in Sint Michielsgestel\, Netherlands. \nOrganized in collaboration by the European Organisation for Research and Treatment of Cancer (EORTC)\, the European Society for Medical Oncology (ESMO)\, and the American Association for Cancer Research (AACR)\, applications are currently open to participate in this highly-regarded course\, which aims to provide comprehensive training on the design and conduct of successful clinical cancer research trials. \nApply.
URL:https://oncodaily.com/event/clinical-cancer-research-421180
LOCATION:De Ruwenberg Hotel\, Ruwenbergstraat 7\, Sint-Michielsgestel\, 5271 AG\, Netherlands
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BeFunky-collage-2025-12-02T101638863-Picsart-AiImageEnhancer.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Copenhagen:20260617T080000
DTEND;TZID=Europe/Copenhagen:20260619T170000
DTSTAMP:20260508T020907
CREATED:20250714T223214Z
LAST-MODIFIED:20250714T223246Z
UID:10000215-1781683200-1781888400@oncodaily.com
SUMMARY:The ESMO Gynaecological Cancers Congress 2026
DESCRIPTION:The ESMO Gynaecological Cancers Congress 2026 will take place from 17–19 June in Copenhagen\, Denmark\, as well as online.  \nThis global event brings together experts\, researchers\, and healthcare professionals to explore the latest advancements in the diagnosis and treatment of ovarian\, cervical\, uterine\, vaginal\, and vulvar cancers. The programme features keynote lectures\, interactive sessions\, and dynamic discussions designed to promote collaboration and accelerate progress in gynaecological oncology. \nWith a strong emphasis on supporting young oncology professionals\, the congress offers opportunities for early-career specialists to present their research\, gain recognition\, and connect with mentors. Scientific Co-Chairs Nicoletta Colombo\, Kosei Hasegawa and Ana Oaknin from Barcelona lead the event\, ensuring a comprehensive and impactful experience for all participants. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodaily.com/event/esmo-329239
LOCATION:Bella Center\, Center Boulevard 5\, Copenhagen\, 2300\, Denmark
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7173.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260624
DTEND;VALUE=DATE:20260625
DTSTAMP:20260508T020907
CREATED:20260104T235612Z
LAST-MODIFIED:20260104T235618Z
UID:10000551-1782259200-1782345599@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Cervical Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Cervical Cancer 2026 is a virtual scientific session scheduled for June 24\, 2026. \nChaired by Ana Oaknin\, the webinar is designed to help oncology professionals translate the latest ESMO Clinical Practice Guidelines (CPG) into daily clinical practice. The program includes a real-world case presentation by Avinash Ramchandani Vaswani\, a critical analysis of the guidelines by Domenica Lorusso\, and a discussion on implementation barriers by Benedetta Pellegrino. \nKey technical topics include the integration of immune checkpoint inhibitors and anti-angiogenic agents for advanced and recurrent disease\, as well as strategies for multidisciplinary collaboration and equitable access to care. Live participants are eligible for 1 ESMO-MORA category 1 point. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-436781
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260626
DTEND;VALUE=DATE:20260628
DTSTAMP:20260508T020907
CREATED:20260120T150529Z
LAST-MODIFIED:20260120T150555Z
UID:10000605-1782432000-1782604799@oncodaily.com
SUMMARY:ESMO Preceptorship on Gastric Cancer 2026: Lisbon
DESCRIPTION:The ESMO Preceptorship on Gastric Cancer 2026 is a specialized educational event scheduled to take place in Lisbon\, Portugal\, from June 26–27\, 2026. Co-chaired by Tania Fleitas and Hanneke van Laarhoven\, this multidisciplinary course is designed to provide oncology professionals with an in-depth understanding of the current standards and emerging therapies for gastric and gastroesophageal junction cancers. \nThe program emphasizes the practical application of evidence-based medicine through expert-led lectures and clinical case discussions\, covering the entire patient journey from early diagnosis and molecular screening to surgical innovations and advanced systemic treatments like immunotherapy. \nApplication.
URL:https://oncodaily.com/event/gastric-cancer-444088
LOCATION:Lisbon\, Portugal
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-GC-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260701
DTEND;VALUE=DATE:20260702
DTSTAMP:20260508T020907
CREATED:20260128T212652Z
LAST-MODIFIED:20260128T212701Z
UID:10000639-1782864000-1782950399@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers: Metastatic Castration-Resistant Prostate Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Metastatic Castration-Resistant Prostate Cancer 2026 is a virtual webinar scheduled for July 1\, 2026\, at 18:30 CEST. \nChaired by Aurelius Gabriel Omlin\, the session focuses on advanced management strategies for mCRPC\, including treatment sequencing\, the potential role of immunotherapy\, and the optimization of patient selection for radioligand therapy. \nThe program features expert presentations from Gunhild Von Amsberg\, Alice Bernard-Tessier\, and Karolien Goffin\, followed by a panel discussion to evaluate clinical data and address remaining unmet needs in the field. This educational activity is available to ESMO members and offers 2 ESMO-MORA category 1 points for live viewers. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-448592
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Deep-Dive.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260701
DTEND;VALUE=DATE:20260703
DTSTAMP:20260508T020907
CREATED:20260120T151018Z
LAST-MODIFIED:20260120T151027Z
UID:10000606-1782864000-1783036799@oncodaily.com
SUMMARY:ESMO Preceptorship on Endometrial Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Endometrial Cancer 2026 is a specialized educational course scheduled for July 1–2\, 2026\, in Lugano\, Switzerland. \nThis intensive program is designed to provide medical oncologists with a comprehensive understanding of the multidisciplinary management of endometrial cancer\, from diagnosis and pathology to advanced therapeutic strategies. Key learning objectives typically include exploring the “new” FIGO staging\, the role of molecular classification in tailoring treatment\, and the revolutionary impact of immunotherapy and combination therapies in recurrent or metastatic disease. \nApplication.
URL:https://oncodaily.com/event/endometrial-cancer-444093
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Lugano-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR